Shanghai Junshi Biosciences Co., Ltd. (688180.SS)
CNY 29.96
(-1.77%)
CNY 29.96
(-1.77%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.28 Billion CNY | 11.57% |
| 2022 | -2.58 Billion CNY | -254.6% |
| 2021 | -728.18 Million CNY | 56.28% |
| 2020 | -1.66 Billion CNY | -123.81% |
| 2019 | -744.23 Million CNY | -3.88% |
| 2018 | -716.41 Million CNY | -123.13% |
| 2017 | -321.07 Million CNY | -143.3% |
| 2016 | -131.96 Million CNY | -127.65% |
| 2015 | -57.97 Million CNY | -129.55% |
| 2014 | -25.25 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -281.81 Million CNY | 22.29% |
| 2024 Q2 | -362.66 Million CNY | -28.14% |
| 2024 Q1 | -283.02 Million CNY | 67.71% |
| 2023 Q1 | -543.43 Million CNY | 31.33% |
| 2023 FY | -2.28 Billion CNY | 11.57% |
| 2023 Q4 | -876.61 Million CNY | -113.6% |
| 2023 Q3 | -410.39 Million CNY | 9.6% |
| 2023 Q2 | -453.98 Million CNY | 16.46% |
| 2022 FY | -2.58 Billion CNY | -254.6% |
| 2022 Q4 | -791.33 Million CNY | -15.79% |
| 2022 Q3 | -683.4 Million CNY | -32.44% |
| 2022 Q1 | -396.39 Million CNY | -20.56% |
| 2022 Q2 | -516 Million CNY | -30.18% |
| 2021 FY | -728.18 Million CNY | 56.28% |
| 2021 Q1 | 377.32 Million CNY | 168.24% |
| 2021 Q2 | -367.97 Million CNY | -197.52% |
| 2021 Q3 | -401.47 Million CNY | -9.1% |
| 2021 Q4 | -328.78 Million CNY | 18.11% |
| 2020 Q1 | -229.35 Million CNY | 24.03% |
| 2020 Q3 | -516.13 Million CNY | -39.43% |
| 2020 FY | -1.66 Billion CNY | -123.81% |
| 2020 Q2 | -370.17 Million CNY | -61.4% |
| 2020 Q4 | -552.94 Million CNY | -7.13% |
| 2019 Q4 | -301.9 Million CNY | -95.32% |
| 2019 Q2 | 85.95 Million CNY | 122.81% |
| 2019 Q1 | -376.88 Million CNY | -31.52% |
| 2019 FY | -744.23 Million CNY | -3.88% |
| 2019 Q3 | -154.57 Million CNY | -279.83% |
| 2018 Q3 | -157.06 Million CNY | 8.53% |
| 2018 FY | -716.41 Million CNY | -123.13% |
| 2018 Q2 | -171.7 Million CNY | -69.72% |
| 2018 Q1 | -101.16 Million CNY | -16.92% |
| 2018 Q4 | -286.56 Million CNY | -82.45% |
| 2017 Q1 | -75.3 Million CNY | -72.93% |
| 2017 FY | -321.07 Million CNY | -143.3% |
| 2017 Q4 | -86.53 Million CNY | -8.49% |
| 2017 Q3 | -79.75 Million CNY | -0.85% |
| 2017 Q2 | -79.08 Million CNY | -5.02% |
| 2016 Q4 | -43.54 Million CNY | 9.53% |
| 2016 FY | -131.96 Million CNY | -127.65% |
| 2016 Q3 | -48.13 Million CNY | -146.53% |
| 2016 Q2 | -19.52 Million CNY | 0.0% |
| 2016 Q1 | -19.52 Million CNY | 11.6% |
| 2015 Q2 | -6.89 Million CNY | 0.0% |
| 2015 Q3 | -22.08 Million CNY | -220.25% |
| 2015 FY | -57.97 Million CNY | -129.55% |
| 2015 Q1 | -6.89 Million CNY | -0.94% |
| 2015 Q4 | -22.08 Million CNY | 0.0% |
| 2014 Q2 | -5.79 Million CNY | 0.0% |
| 2014 Q4 | -6.83 Million CNY | 0.0% |
| 2014 FY | -25.25 Million CNY | 0.0% |
| 2014 Q3 | -6.83 Million CNY | -17.94% |
| 2014 Q1 | -5.79 Million CNY | 0.0% |